Asafe, effective vaccine is the ultimate tool needed to end the coronavirus disease 2019 (COVID-19) pandemic. Biomedical researchers are making progress every day towards such a vaccine, whether it’s devising innovative technologies or figuring out ways to speed human testing. In fact, just this week, NIH’s National Institute of Allergy and Infectious Diseases (NIAID) established a new clinical trials network that will enroll tens of thousands of volunteers in large-scale clinical trials testing a variety of investigational COVID-19 vaccines.
Image: DR. FRANCIS COLLINS Director of the National Institutes of Health (NIH) – https://www.govexec.com
{iframe}https://www.govexec.com/management/2020/07/meet-researcher-leading-nihs-covid-19-vaccine-development-efforts/166758/{/iframe}